Er-Kim Pharma

Er-Kim Pharma is a premier commercial partner for global biopharmaceutical companies, specializing in the commercialization of innovative therapies across Central and Eastern Europe, Turkey, and Greece. Founded in 1981, the company provides a comprehensive suite of services including regulatory affairs, market access, medical affairs, and distribution. Er-Kim focuses on high-unmet-need areas such as rare diseases, oncology, hematology, and neurology. By leveraging deep local expertise and a robust infrastructure, the company enables biotech firms to reach patients in complex markets without the need for a direct local presence. Their portfolio features breakthrough treatments from partners like Alnylam, Alexion, and Incyte, making them a critical player in the regional healthcare ecosystem.